Fingerprint
Dive into the research topics of 'A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
Haeseong Park, Kerry Williams, Nikolaos A. Trikalinos, Sarah Larson, Benjamin Tan, Saiama Waqar, Rama Suresh, Daniel Morgensztern, Brian A. Van Tine, Ramaswamy Govindan, Jingqin Luo, A. Craig Lockhart, Andrea Wang-Gillam
- Section of Medical Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Division of Public Health Sciences
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Oncology
- Institute for Public Health
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Brain Tumor Center
- Mentorship to Enhance Diversity in Academia (MEDA)
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations